Revenues of ORAMED PHARMACEUTICALS INC. from 29 Feb 2016 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
ORAMED PHARMACEUTICALS INC. quarterly and annual Revenues in USD history and change rate from 29 Feb 2016 to 31 Mar 2025.
  • ORAMED PHARMACEUTICALS INC. Revenues for the quarter ending 31 Mar 2025 was $2,000,000.
  • ORAMED PHARMACEUTICALS INC. annual Revenues for 2023 was $1,340,000, a 50% decline from 2022.
  • ORAMED PHARMACEUTICALS INC. annual Revenues for 2022 was $2,703,000, unchanged from 2021.
  • ORAMED PHARMACEUTICALS INC. annual Revenues for 2021 was $2,703,000, a 0.26% decline from 2020.
Source SEC data
View on sec.gov
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)

ORAMED PHARMACEUTICALS INC. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $2,000,000 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q2 2023 $2,926,000 $674,000 $0 0% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $2,926,000 $666,000 $0 0% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $2,926,000 $904,000 $0 0% 01 Sep 2022 31 Dec 2022 10-K 06 Mar 2023 2022 FY
Q3 2022 $2,926,000 $682,000 $0 0% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $2,926,000 $674,000 $0 0% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $2,926,000 $666,000 $0 0% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $2,926,000 $904,000 $0 0% 01 Sep 2021 31 Dec 2021 10-QT 30 Mar 2022 2021 Q2
Q3 2021 $2,926,000 $682,000 +$1,000 +0.15% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $2,925,000 $674,000 -$7,000 -1% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q1 2021 $2,932,000 $666,000 -$8,000 -1.2% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $2,940,000 $904,000 +$230,000 +34% 01 Sep 2020 31 Dec 2020 10-QT 30 Mar 2022 2021 Q2
Q3 2020 $2,710,000 $681,000 $0 0% 01 Jun 2020 31 Aug 2020 10-K 24 Nov 2021 2021 FY
Q2 2020 $2,710,000 $681,000 -$1,000 -0.15% 01 Mar 2020 31 May 2020 10-Q 14 Jul 2021 2021 Q3
Q1 2020 $2,711,000 $674,000 +$8,000 +1.2% 01 Dec 2019 29 Feb 2020 10-Q 13 Apr 2021 2021 Q2
Q4 2019 $2,703,000 $674,000 $0 0% 01 Sep 2019 30 Nov 2019 10-Q 14 Jan 2021 2021 Q1
Q3 2019 $2,703,000 $681,000 +$64,000 +10% 01 Jun 2019 31 Aug 2019 10-K 24 Nov 2020 2020 FY
Q2 2019 $2,639,000 $682,000 +$65,000 +11% 01 Mar 2019 31 May 2019 10-Q 07 Jul 2020 2020 Q3
Q1 2019 $2,574,000 $666,000 +$62,000 +10% 01 Dec 2018 28 Feb 2019 10-Q 06 Apr 2020 2020 Q2
Q4 2018 $2,512,000 $674,000 +$63,000 +10% 01 Sep 2018 30 Nov 2018 10-Q 09 Jan 2020 2020 Q1
Q3 2018 $2,449,000 $617,000 -$1,000 -0.16% 01 Jun 2018 31 Aug 2018 10-K 27 Nov 2019 2019 FY
Q2 2018 $2,450,000 $617,000 $0 0% 01 Mar 2018 31 May 2018 10-Q 10 Jul 2019 2019 Q3
Q1 2018 $2,450,000 $604,000 -$7,000 -1.1% 01 Dec 2017 28 Feb 2018 10-Q 10 Apr 2019 2019 Q2
Q4 2017 $2,457,000 $611,000 +$1,000 +0.16% 01 Sep 2017 30 Nov 2017 10-Q 14 Jan 2019 2019 Q1
Q3 2017 $2,456,000 $618,000 01 Jun 2017 31 Aug 2017 10-K 27 Nov 2019 2019 FY
Q2 2017 $617,000 +$780,000 01 Mar 2017 31 May 2017 10-Q 12 Jul 2018 2018 Q3
Q1 2017 $611,000 +$486,000 +389% 01 Dec 2016 28 Feb 2017 10-Q 09 Apr 2018 2018 Q2
Q4 2016 $610,000 01 Sep 2016 30 Nov 2016 10-Q 11 Jan 2018 2018 Q1
Q2 2016 $163,000 01 Mar 2016 31 May 2016 10-Q 06 Jul 2017 2017 Q3
Q1 2016 $125,000 01 Dec 2015 29 Feb 2016 10-Q 05 Apr 2017 2017 Q2

ORAMED PHARMACEUTICALS INC. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $1,340,000 -$1,363,000 -50% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $2,703,000 $0 0% 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2024 2023 FY
2021 $2,703,000 -$7,000 -0.26% 01 Sep 2020 31 Aug 2021 10-K 24 Nov 2021 2021 FY
2020 $2,710,000 +$7,000 +0.26% 01 Sep 2019 31 Aug 2020 10-K 24 Nov 2021 2021 FY
2019 $2,703,000 +$254,000 +10% 01 Sep 2018 31 Aug 2019 10-K 24 Nov 2020 2020 FY
2018 $2,449,000 -$7,000 -0.28% 01 Sep 2017 31 Aug 2018 10-K 27 Nov 2019 2019 FY
2017 $2,456,000 +$1,815,000 +283% 01 Sep 2016 31 Aug 2017 10-K 27 Nov 2019 2019 FY
2016 $641,000 01 Sep 2015 31 Aug 2016 10-K 28 Nov 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.